This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trudel, M. Articles by D'Agati, V. Search for Related Content PubMed PubMed Citation Articles by Trudel, M. Articles by D'Agati, V.

American Journal of Pathology, Vol 152, 219-229, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression

M Trudel, L Barisoni, J Lanoix and V D'Agati
Institut de Recherches Cliniques de Montreal, Faculte de Medecine de l'Universite de Montreal, Quebec, Canada. trudelm@ircm.umontreal.ca

SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) produced by dysregulation of c-myc in the kidneys. Our previous demonstration that c-myc is overexpressed in human autosomal polycystic kidney disease (ADPKD) prompted us to investigate the pathogenetic role of c-myc in the induction and progression of the cystogenic phenotype in our mouse model. In young SBM kidneys, c-myc was two- to threefold increased with persistent expression levels into adulthood, an age when c-myc is normally undetectable. In situ hybridization analysis of the c- myc transgene demonstrated intense signal specifically overlying glomerular and tubular epithelium of developing cysts in fetal and young kidneys. Increased expression of c-myc correlated with the initiation and progression of the PKD phenotype as evidenced by early tubular and glomerular cysts at E16.5. Cyst number and size increased with age, with co-development of glomerular and tubular epithelial hyperplasia. Consistently, the mean renal proliferative index was increased approximately 5- to 20-fold in noncystic and cystic tubules of newborn SBM animals compared with littermate controls. Similarly, in fetal and newborn kidneys the tubular apoptotic indices were increased approximately three- to ninefold over controls. Both proliferation and apoptotic rates in cystic tubules approached levels in developing tubules from the normal nephrogenic zone. We conclude that the pathogenesis of PKD hinges on a critical imbalance in c-myc regulation of the opposing processes of cell proliferation and apoptosis, recapitulating the cellular phenomena in developing fetal kidney.

This article has been cited by other articles:

				C. L. Edelstein Mammalian Target of Rapamycin and Caspase Inhibitors in Polycystic Kidney Disease Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1219 - 1226. [Abstract] [Full Text] [PDF]

				J. J. Schrick, P. Vogel, A. Abuin, B. Hampton, and D. S. Rice ADP-Ribosylation Factor-Like 3 Is Involved in Kidney and Photoreceptor Development Am. J. Pathol., April 1, 2006; 168(4): 1288 - 1298. [Abstract] [Full Text] [PDF]

				C. Thivierge, A. Kurbegovic, M. Couillard, R. Guillaume, O. Cote, and M. Trudel Overexpression of PKD1 Causes Polycystic Kidney Disease Mol. Cell. Biol., February 15, 2006; 26(4): 1538 - 1548. [Abstract] [Full Text] [PDF]

				Y. Tao, J. Kim, S. Faubel, J. C. Wu, S. A. Falk, R. W. Schrier, and C. L. Edelstein Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease PNAS, May 10, 2005; 102(19): 6954 - 6959. [Abstract] [Full Text] [PDF]

				Y. Tao, J. Kim, R. W. Schrier, and C. L. Edelstein Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease J. Am. Soc. Nephrol., January 1, 2005; 16(1): 46 - 51. [Abstract] [Full Text] [PDF]

				M. C. Hu and N. D. Rosenblum Smad1, {beta}-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription Development, January 1, 2005; 132(1): 215 - 225. [Abstract] [Full Text] [PDF]

				M. C. Hu, T. D. Piscione, and N. D. Rosenblum Elevated SMAD1/{beta}-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice Development, June 15, 2003; 130(12): 2753 - 2766. [Abstract] [Full Text] [PDF]

				M. Rodova, M. R. Islam, R. L. Maser, and J. P. Calvet The Polycystic Kidney Disease-1 Promoter Is a Target of the beta -Catenin/T-cell Factor Pathway J. Biol. Chem., August 9, 2002; 277(33): 29577 - 29583. [Abstract] [Full Text] [PDF]

				M. Couillard, R. Guillaume, N. Tanji, V. D'Agati, and M. Trudel c-myc-induced Apoptosis in Polycystic Kidney Disease Is Independent of FasL/Fas Interaction Cancer Res., April 1, 2002; 62(8): 2210 - 2214. [Abstract] [Full Text] [PDF]

				J. NAUTA, M. A. GOEDBLOED, H. V. HERCK, D. A. HESSELINK, P. VISSER, R. WILLEMSEN, R. P. E. V. DOKKUM, C. J. WRIGHT, and L. M. GUAY-WOODFORD New Rat Model that Phenotypically Resembles Autosomal Recessive Polycystic Kidney Disease J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2272 - 2284. [Abstract] [Full Text]

				J. L. RICKER, V. H. GATTONE II, J. P. CALVET, and C. A. RANKIN Development of Autosomal Recessive Polycystic Kidney Disease in BALB/c-cpk/cpk Mice J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1837 - 1847. [Abstract] [Full Text]

				M. Koptides, R. Mean, K. Demetriou, A. Pierides, and C. C. Deltas Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease Hum. Mol. Genet., February 12, 2000; 9(3): 447 - 452. [Abstract] [Full Text] [PDF]

				J. van Adelsberg Polycystin-1 interacts with E-cadherin and the catenins--clues to the pathogenesis of cyst formation in ADPKD? Nephrol. Dial. Transplant., January 1, 2000; 15(1): 1 - 2. [Full Text] [PDF]